Lab
JL Rivera & Sons INC
JL Rivera & Sons INC was paid $257K by Medicaid between Jan 2018 and Dec 2024, across 39 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 16% of everything it billed.
33Billing provider infoJL RIVERA & SONS INC
GUAYAMA, PR 00784
GUAYAMA, PR 00784
33aNPI1356797377assigned 05/09/2016
33bProvider typeClinical Medical Laboratory
28Total paid$257K
24GClaims23,945
24DCodes billed39
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#410 of 777
Median peer was paid$278K
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,123 | $8K | |
| 2019 | 1,632 | $14K | |
| 2020 | 1,675 | $21K | |
| 2021 | 3,738 | $48K | |
| 2022 | 3,358 | $39K | |
| 2023 | 5,481 | $54K | |
| 2024incomplete | 6,938 | $72K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 16% | 2,696 | 2,255 | $41K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 15% | 757 | 668 | $38K |
| 80061 | Lipid panel | 13% | 2,704 | 2,205 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 4,518 | 3,666 | $30K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.6% | 641 | 564 | $14K |
| 80053 | Comprehensive metabolic panel | 5.2% | 1,346 | 1,034 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.7% | 1,647 | 1,447 | $12K |
| 81000 | 4.4% | 3,645 | 2,914 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.8% | 1,103 | 861 | $10K |
| 82274 | 3.5% | 673 | 543 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.1% | 297 | 192 | $8K |
| 80076 | 2.0% | 736 | 616 | $5K |
27 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 118 | $4K |
| 86328 | 1.3% | 184 | $3K | |
| 87276 | 1.3% | 253 | $3K | |
| 82043 | 1.3% | 645 | $3K | |
| 87275 | 1.1% | 253 | $3K | |
| 86738 | 1.0% | 233 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 187 | $2K |
| 86701 | <1% | 188 | $2K | |
| 84153 | <1% | 82 | $1K | |
| 82570 | <1% | 214 | $1K | |
| 86301 | <1% | 44 | $795.96 | |
| 87088 | <1% | 103 | $776.67 | |
| 82378 | <1% | 45 | $718.25 | |
| 87186 | <1% | 93 | $717.41 | |
| 82105 | <1% | 49 | $704.50 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 19 | $606.49 |
| 86592 | <1% | 156 | $592.12 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 78 | $549.83 |
| 85730 | <1% | 55 | $330.79 | |
| 84439 | <1% | 38 | $314.01 | |
| 85610 | <1% | 55 | $235.06 | |
| 86803 | <1% | 18 | $223.22 | |
| 87590 | <1% | 19 | $212.36 | |
| 86800 | <1% | 13 | $166.42 | |
| 86376 | <1% | 12 | $139.57 | |
| 87070 | <1% | 14 | $103.30 | |
| 87077 | <1% | 14 | $96.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIVERA IRIZARRY, LAURA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Policlinica San Pedro PSC | Arroyo, PR | $3K |
| JL Rivera & Sons INC | Guayama, PR | $734.11 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.